Battling qPCR Royalty Decline, Life Tech Reports 2 Percent Uptick in Q4 Genetic Analysis Revenues | GenomeWeb

Life Technologies this week reported a 2 percent increase in fourth-quarter revenues amid flat full-year revenues for its Genetic Analysis business unit, which includes the company's PCR and CE research instruments, sequencing products, and associated consumables.

The company said that growth in the Genetic Analysis unit was driven primarily by its Ion Torrent sequencing products, overcoming an expected decline in its SOLiD sequencing product line and in qPCR royalty payments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.